PATENT CLAIM ANALYSIS

Application Number: 15760660
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-02
Patent Classification: ["424", "130100"]

Abstract:
Methods of diagnosis and methods of treatment and prevention for autism spectrum disorder are provided using decoy antigens to maternal brain-reactive antibodies.

Claim (Index 1):
A method of inhibiting or reducing development of an autism spectrum disorder in a fetus or an infant comprising administering to a mother pregnant with the fetus or prior to the fetus being born as an infant while the mother is pregnant, an amount of an agent which binds an antibody directed to Caspr2, KCNAB2, KCNAB1, endothelial integrin ligand (EDIL3), IVD, brain specific sultatransferase (SULT4A1), TNIP2, retinoic acid induced 16 (RAI16) or GDP D5, effective to inhibit or reduce development of an autism spectrum disorder in a fetus or an infant.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 90.0
- Lexical Diversity: 1.09524
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15042976', '12266814', '11381943', '15353037', '15136021']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7062856259435379
- 35 USC 102 Novelty (BERT): 0.4862690434999836
- Combined Prediction Score: 0.6842839676991825
- Mean Citation Score: 172.780086
- Max Citation Score: 210.8995
- Similarity Product: 156.15148913949727

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test